These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 31688455

  • 1. Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia.
    Carr RM, Patnaik MM.
    Curr Opin Hematol; 2020 Jan; 27(1):2-10. PubMed ID: 31688455
    [Abstract] [Full Text] [Related]

  • 2. Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
    Patnaik MM, Lasho T.
    Hematology Am Soc Hematol Educ Program; 2020 Dec 04; 2020(1):460-464. PubMed ID: 33275673
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Cull AH, Mahendru D, Snetsinger B, Good D, Tyryshkin K, Chesney A, Ghorab Z, Reis M, Buckstein R, Wells RA, Rauh MJ.
    Leuk Res; 2018 Feb 04; 65():5-13. PubMed ID: 29227812
    [Abstract] [Full Text] [Related]

  • 4. Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
    Patnaik MM, Lasho TL.
    Hematology Am Soc Hematol Educ Program; 2020 Dec 04; 2020(1):450-459. PubMed ID: 33275756
    [Abstract] [Full Text] [Related]

  • 5. Epigenetic regulation by ASXL1 in myeloid malignancies.
    Yang FC, Agosto-Peña J.
    Int J Hematol; 2023 Jun 04; 117(6):791-806. PubMed ID: 37062051
    [Abstract] [Full Text] [Related]

  • 6. Srsf2P95H/+ co-operates with loss of TET2 to promote myeloid bias and initiate a chronic myelomonocytic leukemia-like disease in mice.
    Xu JJ, Chalk AM, Wall M, Langdon WY, Smeets MF, Walkley CR.
    Leukemia; 2022 Dec 04; 36(12):2883-2893. PubMed ID: 36271153
    [Abstract] [Full Text] [Related]

  • 7. Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
    Tsai SC, Shih LY, Liang ST, Huang YJ, Kuo MC, Huang CF, Shih YS, Lin TH, Chiu MC, Liang DC.
    Clin Cancer Res; 2015 Aug 01; 21(15):3541-51. PubMed ID: 25840971
    [Abstract] [Full Text] [Related]

  • 8. An evolutionary perspective on chronic myelomonocytic leukemia.
    Itzykson R, Solary E.
    Leukemia; 2013 Jul 01; 27(7):1441-50. PubMed ID: 23558522
    [Abstract] [Full Text] [Related]

  • 9. Age-related mutations and chronic myelomonocytic leukemia.
    Mason CC, Khorashad JS, Tantravahi SK, Kelley TW, Zabriskie MS, Yan D, Pomicter AD, Reynolds KR, Eiring AM, Kronenberg Z, Sherman RL, Tyner JW, Dalley BK, Dao KH, Yandell M, Druker BJ, Gotlib J, O'Hare T, Deininger MW.
    Leukemia; 2016 Apr 01; 30(4):906-13. PubMed ID: 26648538
    [Abstract] [Full Text] [Related]

  • 10. Clonal architecture of chronic myelomonocytic leukemias.
    Itzykson R, Kosmider O, Renneville A, Morabito M, Preudhomme C, Berthon C, Adès L, Fenaux P, Platzbecker U, Gagey O, Rameau P, Meurice G, Oréar C, Delhommeau F, Bernard OA, Fontenay M, Vainchenker W, Droin N, Solary E.
    Blood; 2013 Mar 21; 121(12):2186-98. PubMed ID: 23319568
    [Abstract] [Full Text] [Related]

  • 11. Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
    Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu B.
    Clin Transl Oncol; 2021 Sep 21; 23(9):1731-1742. PubMed ID: 33861431
    [Abstract] [Full Text] [Related]

  • 12. How I diagnose and treat chronic myelomonocytic leukemia.
    Patnaik MM.
    Haematologica; 2022 Jul 01; 107(7):1503-1517. PubMed ID: 35236051
    [Abstract] [Full Text] [Related]

  • 13. Oligo-monocytic CMML and other pre-CMML states: Clinical impact, prognostication and management.
    Valent P.
    Best Pract Res Clin Haematol; 2020 Jun 01; 33(2):101137. PubMed ID: 32460976
    [Abstract] [Full Text] [Related]

  • 14. Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.
    Coltro G, Patnaik MM.
    Curr Oncol Rep; 2019 Nov 14; 21(11):101. PubMed ID: 31728739
    [Abstract] [Full Text] [Related]

  • 15. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C, Fermo E, Corti S, Molteni M, Faricciotti A, Cortelezzi A, Lambertenghi Deliliers G, Beran M, Onida F.
    Clin Cancer Res; 2010 Apr 15; 16(8):2246-56. PubMed ID: 20371679
    [Abstract] [Full Text] [Related]

  • 16. Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series.
    Martin de Frémont G, Hirsch P, Gimenez de Mestral S, Moguelet P, Ditchi Y, Emile JF, Senet P, Georgin-Lavialle S, Hanslik T, Maurier F, Adedjouma A, Abisror N, Mahevas T, Malard F, Adès L, Fenaux P, Fain O, Chasset F, Mekinian A.
    Front Immunol; 2021 Apr 15; 12():715053. PubMed ID: 34671345
    [Abstract] [Full Text] [Related]

  • 17. Juvenile myelomonocytic leukemia - A bona fide RASopathy syndrome.
    Lasho T, Patnaik MM.
    Best Pract Res Clin Haematol; 2020 Jun 15; 33(2):101171. PubMed ID: 32460983
    [Abstract] [Full Text] [Related]

  • 18. Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients.
    Coltro G, Mangaonkar AA, Lasho TL, Finke CM, Pophali P, Carr R, Gangat N, Binder M, Pardanani A, Fernandez-Zapico M, Robertson KD, Bosi A, Droin N, Vannucchi AM, Tefferi A, Hunter A, Padron E, Solary E, Patnaik MM.
    Leukemia; 2020 May 15; 34(5):1407-1421. PubMed ID: 31836856
    [Abstract] [Full Text] [Related]

  • 19. Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.
    Zoi K, Cross NC.
    Int J Hematol; 2015 Mar 15; 101(3):229-42. PubMed ID: 25212680
    [Abstract] [Full Text] [Related]

  • 20. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].
    Qu SQ, Pan LJ, Qin TJ, Xu ZF, Li B, Wang HJ, Sun Q, Jia YJ, Li CW, Cai WY, Gao QY, Jiao M, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2023 May 14; 44(5):373-379. PubMed ID: 37550186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.